Despite advances in surgery and chemotherapy, survival of people with certain types of ovarian cancer has not significantly changed in decades. That has meant that some ovarian cancer patients go through treatments that don't ...
Aug 3, 2023
0
16
Scientists from the Terasaki Institute for Biomedical Innovation (TIBI) have developed a nanoengineered bioink with improved bonding and cross-linking capabilities for 3D bioprinting of tumor models. A key component of this ...
Aug 3, 2023
0
21
Thanks to machine learning algorithms, short pieces of DNA floating in the bloodstream of cancer patients can help doctors diagnose specific types of cancer and choose the most effective treatment for a patient.
Aug 2, 2023
0
21
A new editorial paper titled "Targeting H3K27me3 loss in pediatric brain tumors—a perspective on epigenetically guided cancer therapy" has been published in Oncotarget.
Aug 2, 2023
0
0
CAR-T immune therapies could be effective against solid tumors if the right targets are identified, a new study led by University of Illinois Urbana-Champaign researchers suggests. The researchers have successfully deployed ...
Aug 1, 2023
0
83
Cases of human papillomavirus (HPV)-associated cancers of the head and neck, known as head and neck squamous cell carcinoma (HNSCC), are rapidly increasing throughout the United States. Unfortunately, relatively little is ...
Jul 31, 2023
0
20
More than 14,490 people in the U.S. will be diagnosed with glioblastoma in 2023, according to the National Brain Tumor Society, and 10,000 people in the U.S. will die of the disease. The five-year survival rate is 6.9%, and ...
Jul 22, 2023
0
2
Ovarian cancer is the fourth-leading cause of cancer mortality among women and is characterized by late detection, extensive metastasis and poor prognosis.
Jul 19, 2023
0
61
A new study links a high body mass index (BMI) to alterations in the structure and environment of cancerous tumors.
Jul 19, 2023
0
1
Giving patients with operable pancreatic cancers a three-pronged combination immunotherapy treatment consisting of the pancreatic cancer vaccine GVAX, the immune checkpoint therapy nivolumab and urelemab, an anti-CD137 agonist ...
Jul 17, 2023
0
46
